series-c-plus
Stage
1
Investors
About
Develops a drug delivery platform that encapsulates therapeutic molecules into a patient's own red blood cells to enable sustained or targeted drug delivery.
Explore EryDel's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.